Study identifies Δ42PD-1 as novel therapeutic target for hepatocellular carcinoma immunotherapy

Press/Media: Press / Media

PeriodDec 15 2022

Media coverage

1

Media coverage

  • TitleStudy identifies Δ42PD-1 as novel therapeutic target for hepatocellular carcinoma immunotherapy
    Media name/outletNews-Medical.Net
    Country/TerritoryAustralia
    Date12/15/22
    PersonsLi Liu